Diabetes in Individuals With Tuberous Sclerosis Complex Treated With mTOR Inhibitors.
Agricola, K; Stires, G; Krueger, DA; Capal, JK; Franz, DN; Ritter, DM.
Pediatric Neurology.
2021;
120:7-10.
Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex.
Ebrahimi-Fakhari, D; Agricola, KD; Tudor, C; Krueger, D; Franz, DN.
Pediatric Neurology.
2020;
105:59-61.
Improvement in Renal Cystic Disease of Tuberous Sclerosis Complex After Treatment with Mammalian Target of Rapamycin Inhibitor.
Siroky, BJ; Towbin, AJ; Trout, AT; Schaefer, H; Thamann, AR; Agricola, KD; Tudor, C; Capal, J; Dixon, BP; Krueger, DA; et al.
Journal of Pediatrics.
2017;
187:318-322.e2.
Long-term treatment of epilepsy with everolimus in tuberous sclerosis.
Krueger, DA; Wilfong, AA; Mays, M; Talley, CM; Agricola, K; Tudor, C; Capal, J; Holland-Bouley, K; Franz, DN.
Neurology.
2016;
87:2408-2415.